Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H McMahon

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
The Lancet. HIV|October 2, 2015
90-90-90: how do we get there?James H McMahon, Nicholas Medland
The American Journal of Medicine|February 27, 2021
Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A CommentTony M Korman, James H McMahon
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2008
Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosisJames H McMahon, M Lindsay Grayson
The European Respiratory Journal|January 19, 2023
How do we enhance protective immunity to COVID-19 in lung transplant recipients?David W J Griffin, James H McMahon
The New England Journal of Medicine|July 11, 2020
Remdesivir for the Treatment of Covid-19 - Preliminary ReportJames H McMahon, Andrew Udy, Anton Y Peleg
The Journal of Antimicrobial Chemotherapy|December 17, 2020
Bringing evidence from press release to the clinic in the era of COVID-19James H McMahon, Michael J Lydeamore, Andrew J Stewardson
The Lancet. HIV|November 12, 2023
Long-acting cabotegravir PrEP: a time for cautious optimismDavid Wj Griffin, Jennifer F Hoy, James H McMahon
The Medical Journal of Australia|August 3, 2021
Updated Australian guidance for health care providers about "undetectable = untransmittable" for HIVJames H McMahon, Brent Allan, Daniel Grace, et al.
Scandinavian Journal of Infectious Diseases|September 14, 2007
Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?James H McMahon, Jason M O'keeffe, , et al.
The New England Journal of Medicine|August 17, 2023
Meningococcal Vaccine in Mali and GambiaDavid W J Griffin, Jennifer F Hoy, James H McMahon
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
The Lancet. HIV|October 2, 2015
90-90-90: how do we get there?James H McMahon, Nicholas Medland
The American Journal of Medicine|February 27, 2021
Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A CommentTony M Korman, James H McMahon
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 25, 2008
Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosisJames H McMahon, M Lindsay Grayson
The European Respiratory Journal|January 19, 2023
How do we enhance protective immunity to COVID-19 in lung transplant recipients?David W J Griffin, James H McMahon
The New England Journal of Medicine|July 11, 2020
Remdesivir for the Treatment of Covid-19 - Preliminary ReportJames H McMahon, Andrew Udy, Anton Y Peleg
The Journal of Antimicrobial Chemotherapy|December 17, 2020
Bringing evidence from press release to the clinic in the era of COVID-19James H McMahon, Michael J Lydeamore, Andrew J Stewardson
The Lancet. HIV|November 12, 2023
Long-acting cabotegravir PrEP: a time for cautious optimismDavid Wj Griffin, Jennifer F Hoy, James H McMahon
The Medical Journal of Australia|August 3, 2021
Updated Australian guidance for health care providers about "undetectable = untransmittable" for HIVJames H McMahon, Brent Allan, Daniel Grace, et al.
Scandinavian Journal of Infectious Diseases|September 14, 2007
Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?James H McMahon, Jason M O'keeffe, , et al.
The New England Journal of Medicine|August 17, 2023
Meningococcal Vaccine in Mali and GambiaDavid W J Griffin, Jennifer F Hoy, James H McMahon
Pageof 8